ENCAPSULATE INC. — National Aeronautics and Space Administration SBIR Phase II: PHASE II SBIR - 80NSSC25C0036 NVASIVE: AN AI AND MACHINE LEARNING APPROACH FOR METASTASIS

ENCAPSULATE INC. — SBIR Phase II award from National Aeronautics and Space Administration.

Phase II SBIR prototype / development signal

  • Phase II is where National Aeronautics and Space Administration funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
  • Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
  • Obligated amount $899,787 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
  • Tagged technology areas: Artificial Intelligence/ML, Human Performance & Medical, Space & Satellite. Follow those hubs for open topics and peer winners in the same cluster.

Informational capture context from public federal data — not legal or bid advice.

Summary

Encapsulate Inc. received a NASA SBIR Phase II award of nearly $900k to develop an AI and machine learning tool called NVASIVE that predicts cancer metastasis using microgravity data.

Amount
$899,787
Agency
National Aeronautics and Space Administration · National Aeronautics and Space Administration
Program / Phase
SBIR · Phase II
NAICS
541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
Place of performance
CT
Period
2025-07-16 → 2027-07-15

Technology domains

Artificial Intelligence/ML Human Performance & Medical Space & Satellite

Description

PHASE II SBIR - 80NSSC25C0036 NVASIVE: AN AI AND MACHINE LEARNING APPROACH FOR METASTASIS PREDICTION USING NVASIVE AND MICROGRAVITY

View on USASpending.gov ↗